Cite

HARVARD Citation

    Sun, W. et al. (2021). Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases. Clinical pharmacology in drug development. 10 (7), pp. 734-747. [Online]. 
  
Back to record